ArticleDiabetes, obesity & metabolism2026

Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study by obesity and cardiovascular disease status.

Franziska S Ulrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.